An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
InformedHealth.org [Internet].
Cologne, Germany: Institute for Quality and Efficiency in Health Care (IQWiG); 2006-.
Top results in this bookTable of Contents
Major Trauma: Assessment and Initial Management.
National Clinical Guideline Centre (UK).
London: National Institute for Health and Care Excellence (NICE); 2016 Feb. (NICE Guideline, No. 39.)
The CBHSQ Report.
Rockville (MD): Substance Abuse and Mental Health Services Administration (US); 2013-.
Bladder Cancer: Diagnosis and Management.
National Collaborating Centre for Cancer (UK).
London: National Institute for Health and Care Excellence (NICE); 2015 Feb. (NICE Guideline, No. 2.)
Blood Transfusion.
London: National Institute for Health and Care Excellence (NICE); 2015 Nov. (NICE Guideline, No. 24.)
Preoperative Tests (Update): Routine Preoperative Tests for Elective Surgery.
National Guideline Centre (UK).
London: National Institute for Health and Care Excellence (NICE); 2016 Apr. (NICE Guideline, No. 45.)
Fractures (Non-Complex): Assessment and Management.
London: National Institute for Health and Care Excellence (NICE); 2016 Feb. (NICE Guideline, No. 38.)
Spinal Injury: Assessment and Initial Management.
London: National Institute for Health and Care Excellence (NICE); 2016 Feb. (NICE Guideline, No. 41.)
Major Trauma: Service Delivery.
London: National Institute for Health and Care Excellence (NICE); 2016 Feb. (NICE Guideline, No. 40.)
GeneReviews® [Internet].
Adam MP, Feldman J, Mirzaa GM, et al., editors.
Seattle (WA): University of Washington, Seattle; 1993-2024.
Physical Health of People in Prison: Assessment, Diagnosis and Management of Physical Health Problems.
London: National Institute for Health and Care Excellence (NICE); 2016 Nov. (NICE Guideline, No. 57.)
Cirrhosis in Over 16s: Assessment and Management.
London: National Institute for Health and Care Excellence (NICE); 2016 Jul. (NICE Guideline, No. 50.)
Multimorbidity: Assessment, Prioritisation and Management of Care for People with Commonly Occurring Multimorbidity.
London: National Institute for Health and Care Excellence (NICE); 2016 Sep. (NICE Guideline, No. 56.)
Non-Alcoholic Fatty Liver Disease: Assessment and Management.
London: National Institute for Health and Care Excellence (NICE); 2016 Jul. (NICE Guideline, No. 49.)
Children's Attachment: Attachment in Children and Young People Who Are Adopted from Care, in Care or at High Risk of Going into Care.
National Collaborating Centre for Mental Health (UK).
London: National Institute for Health and Care Excellence (NICE); 2015 Nov. (NICE Guideline, No. 26.)
Some Drugs and Herbal Products.
IARC Working Group on the Evaluation of Carcinogenic Risks to Humans.
Lyon (FR): International Agency for Research on Cancer; 2016. (IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, No. 108.)
Adalimumab, etanercept, infliximab, certolizumab pegol, golimumab, tocilizumab and abatacept for the treatment of rheumatoid arthritis not previously treated with disease-modifying antirheumatic drugs and after the failure of conventional disease-modifying antirheumatic drugs only: systematic review and economic evaluation.
Stevenson M, Archer R, Tosh J, et al.
Southampton (UK): NIHR Journals Library; 2016 Apr. (Health Technology Assessment, No. 20.35.)
The Handbook of Salutogenesis [Internet].
Mittelmark MB, Sagy S, Eriksson M, et al., editors.
Cham (CH): Springer; 2017.
Equity of utilisation of cardiovascular care and mental health services in England: a cohort-based cross-sectional study using small-area estimation.
Asthana S, Gibson A, Bailey T, et al.
Southampton (UK): NIHR Journals Library; 2016 Apr. (Health Services and Delivery Research, No. 4.14.)
The effectiveness and cost-effectiveness of erythropoiesis-stimulating agents (epoetin and darbepoetin) for treating cancer treatment-induced anaemia (including review of technology appraisal no. 142): a systematic review and economic model.
Crathorne L, Huxley N, Haasova M, et al.
Southampton (UK): NIHR Journals Library; 2016 Feb. (Health Technology Assessment, No. 20.13.)
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on